AbbVie 2019 revenue forecast tops Wall Street estimates while it eyes future Botox sales
Go back to AbbVie 2019 revenue forecast tops Wall Street estimates while it eyes future Botox sales| AbbVie (NYSE: ABBV) | Delayed: 234.76 +4.75 (2.07%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $230.01 | 52 Week High | $68.12 | |||
| Open | $232.97 | 52 Week Low | $50.71 | |||
| Day High | $235.31 | P/E | 50.92 | |||
| Day Low | $231.30 | EPS | $4.61 | |||
| Volume | 7,492,924 | |||||
| Allergan Inc (NYSE: AGN) | Delayed: 193.02 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $193.02 | 52 Week High | $322.68 | |||
| Open | $15.33 | 52 Week Low | $186.34 | |||
| Day High | $193.02 | P/E | 45.96 | |||
| Day Low | $193.02 | EPS | $4.20 | |||
| Volume | 43,377 | |||||
| (NASDAQ: EOLS) | Delayed: 6.74 +0.15 (2.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.59 | 52 Week High | $ | |||
| Open | $6.61 | 52 Week Low | $ | |||
| Day High | $6.90 | P/E | N/A | |||
| Day Low | $6.53 | EPS | $ | |||
| Volume | 547,591 | |||||

